Cargando…

Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes Mellitus, Obesity and Diabetic Kidney Disease

Diabetes mellitus (DM) burden encompasses diabetic kidney disease (DKD), the leading cause of end-stage renal disease worldwide. Despite compelling evidence indicating that pharmacological intervention curtails DKD progression, the search for non-pharmacological strategies can identify novel targets...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastos, Rosana M. C., Simplício-Filho, Antônio, Sávio-Silva, Christian, Oliveira, Luiz Felipe V., Cruz, Giuliano N. F., Sousa, Eliza H., Noronha, Irene L., Mangueira, Cristóvão L. P., Quaglierini-Ribeiro, Heloísa, Josefi-Rocha, Gleice R., Rangel, Érika B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998923/ https://www.ncbi.nlm.nih.gov/pubmed/35409202 http://dx.doi.org/10.3390/ijms23073842

Ejemplares similares

Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity
por: Sávio-Silva, Christian, et al.
Publicado: (2021)

Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
por: Sávio-Silva, Christian, et al.
Publicado: (2020)

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
por: Paulini, Janaina, et al.
Publicado: (2016)

Excessive cholecalciferol supplementation increases kidney dysfunction associated with intrarenal artery calcification in obese insulin-resistant mice
por: Almeida, Youri E., et al.
Publicado: (2020)

Gut microbiota-derived metabolites are novel targets for improving insulin resistance
por: Bastos, Rosana MC, et al.
Publicado: (2022)

The fecal metabolome is associated with gestational diabetes mellitus
por: Liang, Shufen, et al.
Publicado: (2019)

Dynamic Development of Fecal Microbiome During the Progression of Diabetes Mellitus in Zucker Diabetic Fatty Rats
por: Zhou, Wen, et al.
Publicado: (2019)

Fecal microbiota imbalance in Mexican children with type 1 diabetes
por: Mejía-León, María Esther, et al.
Publicado: (2014)

Hyperkalemia in Diabetes Mellitus Setting
por: Goia-Nishide, Kleber, et al.
Publicado: (2022)

Hypokalemia in Diabetes Mellitus Setting
por: Coregliano-Ring, Lucas, et al.
Publicado: (2022)

Personalized medicine and the clinical laboratory
por: Pinho, João Renato Rebello, et al.
Publicado: (2014)

Is Fecal Leukocyte Test a good predictor of Clostridium difficile associated diarrhea?
por: Reddymasu, Savio, et al.
Publicado: (2006)

Gut Microbiota Composition and Fecal Metabolic Profiling in Patients With Diabetic Retinopathy
por: Zhou, Zixi, et al.
Publicado: (2021)

Is There a Role for Diabetes-Specific Nutrition Formulas as Meal Replacements in Type 2 Diabetes?
por: Noronha, Jarvis C., et al.
Publicado: (2022)

Infections in children with diabetes()
por: Calliari, Luis Eduardo, et al.
Publicado: (2019)

Imbalance of Fecal Microbiota at Newly Diagnosed Type 1 Diabetes in Chinese Children
por: Qi, Cui-Juan, et al.
Publicado: (2016)

Fecal microbiota transplantation relieve painful diabetic neuropathy: A case report
por: Cai, Ting-ting, et al.
Publicado: (2018)

Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model
por: Yang, Mei, et al.
Publicado: (2020)

Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022)

Proinflammatory Cytokine Expression in Apical Periodontitis from Diabetic Patients
por: Borgo Sarmento, Estéfano, et al.
Publicado: (2023)

Simplified method of plantigrafia for assessing the feet of diabetic patients
por: Martínez, Beatriz Bertolaccini, et al.
Publicado: (2015)

Analysis of serum inflammatory mediators in type 2 diabetic patients and their influence on renal function
por: Araújo, Liliane Silvano, et al.
Publicado: (2020)

Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Micro- and Macrovascular Complications in Diabetes Mellitus: Preclinical and Clinical Studies
por: Rangel, Érika B., et al.
Publicado: (2019)

Oleanolic Acid Initiates Apoptosis in Non-Small Cell Lung Cancer Cell Lines and Reduces Metastasis of a B16F10 Melanoma Model In Vivo
por: Lúcio, Kelly Araújo, et al.
Publicado: (2011)

Differentiating Induced Pluripotent Stem Cells into Renal Cells: A New Approach to Treat Kidney Diseases
por: de Carvalho Ribeiro, Patrícia, et al.
Publicado: (2020)

Influence of whole-wheat consumption on fecal microbial community structure of obese diabetic mice
por: Garcia-Mazcorro, Jose F., et al.
Publicado: (2016)

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
por: de Groot, Pieter F., et al.
Publicado: (2017)

Fecal microbiota transplantation alters the susceptibility of obese rats to type 2 diabetes mellitus
por: Zhang, Lijing, et al.
Publicado: (2020)

Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how
por: Hou, Kaijian, et al.
Publicado: (2022)

Fecal Bacterial Community and Metagenome Function in Asians with Type 2 Diabetes, According to Enterotypes
por: Wu, Xuangao, et al.
Publicado: (2022)

Effect of Benaglutide on Gut Microbiota and Fecal Metabolites in Patients with Type 2 Diabetes Mellitus
por: Han, Chen-Yu, et al.
Publicado: (2023)

Electrodiagnostic Testing Characteristics of Diabetic People with Carpal Tunnel Syndrome
por: Paiva Filho, Henver Ribeiro, et al.
Publicado: (2021)

Comparative Analysis between Ecotoxicity of Nitrogen-, Phosphorus-, and Potassium-Based Fertilizers and Their Active Ingredients
por: Simplício, Nathan de Castro Soares, et al.
Publicado: (2016)

Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
por: Bustinduy, Amaya L., et al.
Publicado: (2013)

Meal Replacements for Weight-Related Complications in Type 2 Diabetes: What Is the State of the Evidence?
por: Noronha, Jarvis C., et al.
Publicado: (2022)

The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review
por: Bento, Laiz Cameirão, et al.
Publicado: (2017)

Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population
por: Lê, Kim-Anne, et al.
Publicado: (2013)

The Fecal Microbiota Is Already Altered in Normoglycemic Individuals Who Go on to Have Type 2 Diabetes
por: Wang, Li, et al.
Publicado: (2021)

Risk of Diabetes in Subjects with Positive Fecal Immunochemical Test: A Nationwide Population-Based Study
por: Kim, Kwang Woo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uqmtankr846n981sr3u4sjcjlr